LEP and gestational diabetes: In gestational diabetes mellitus (GDM), calycosin exerts efficient effects that suppress inflammation and strengthen beta cells’ function, aiding in treating GDM in pregnant C57BL/KsJ-Lep (db/+) diabetic mice at the doses of 15 and 30 mg/kg.